Medice Arzneimittel Puetter GmbH & Co. KG
PolandAll drugs from this manufacturer
-
The medicine is intended for the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It is used when previous methods, such as behavioral therapy or psychological counseling, have proven insufficient.
Dosage form: capsules, hard modified release
Active substance Dosage methylphenidate hydrochloride 5 mg ATC: N06BA04
-
The medicine is intended for the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It is used when other methods, such as behavioral therapy or psychological counseling, have proven insufficient.
Dosage form: capsules, hard modified release
Active substance Dosage methylphenidate hydrochloride 10 mg ATC: N06BA04
-
The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It may help to extend attention span, improve concentration, and reduce impulsive behavior.
Dosage form: capsules, hard modified release
Active substance Dosage methylphenidate hydrochloride 20 mg ATC: N06BA04
-
The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It may help to extend attention span, improve concentration, and reduce impulsive behavior.
Dosage form: capsules, hard modified release
Active substance Dosage methylphenidate hydrochloride 30 mg ATC: N06BA04
-
The medicine is intended for the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It is used when previous methods, such as behavioral therapy or psychological counseling, have proven insufficient.
Dosage form: capsules, hard modified release
Active substance Dosage methylphenidate hydrochloride 40 mg ATC: N06BA04
-
The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It may help to extend attention span, improve concentration, and reduce impulsive behavior.
Dosage form: capsules, hard modified release
Active substance Dosage methylphenidate hydrochloride 50 mg ATC: N06BA04
-
The medicine is intended for the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It is used when previous methods, such as behavioral therapy or psychological counseling, have proven insufficient.
Dosage form: capsules, hard modified release
Active substance Dosage methylphenidate hydrochloride 60 mg ATC: N06BA04
-
The medicine is used to treat attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults. In adults, it is used when symptoms are very bothersome and were present during childhood.
Dosage form: tablets, film-coated
Active substance Dosage atomoxetine hydrochloride 10 mg ATC: N06BA09
-
The medicinal product is used to treat attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults. In adults, it is used when symptoms are very troublesome and were present during childhood.
Dosage form: tablets, film-coated
Active substance Dosage atomoxetine hydrochloride 18 mg ATC: N06BA09
-
The medicinal product is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults. In adults, it is used when symptoms are very bothersome and were present during childhood.
Dosage form: tablets, film-coated
Active substance Dosage atomoxetine hydrochloride 25 mg ATC: N06BA09
-
The medicine is used to treat attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults. It helps to increase concentration and reduce impulsivity and excessive restlessness.
Dosage form: tablets, film-coated
Active substance Dosage atomoxetine hydrochloride 40 mg ATC: N06BA09
-
The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults. It helps to increase concentration and reduce impulsivity and excessive hyperactivity.
Dosage form: tablets, film-coated
Active substance Dosage atomoxetine hydrochloride 60 mg ATC: N06BA09
-
The medicine is used to treat attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults. It is part of a full treatment program, which also includes non-pharmacological methods, such as behavioral therapy.
Dosage form: tablets, film-coated
Active substance Dosage atomoxetine hydrochloride 80 mg ATC: N06BA09
-
The medicinal product is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults (in adults, if symptoms are very bothersome and were present in childhood).
Dosage form: tablets, film-coated
Active substance Dosage atomoxetine hydrochloride 100 mg ATC: N06BA09
-
It is used for the local, short-term support of the treatment of mild to moderate inflammation of the throat and oral cavity, such as sore throat making swallowing difficult, as well as inflammation of the gums and oral mucosa.
Dosage form: tablets, for sucking
Active substance Dosage tyrothricin 0.5 mg benzalkonium chloride 1 mg benzocaine 1.5 mg ATC: R02AA20
-
The medicinal product is used for local, short-term support in the treatment of mild to moderate inflammation of the throat and oral cavity, such as sore throat with pain and difficulty swallowing, as well as inflammation of the oral mucosa and gums.
Dosage form: tablets, for sucking
Active substance Dosage tyrothricin 0.5 mg benzalkonium chloride 1 mg benzocaine 1.5 mg ATC: R02AA20
-
The medicinal product is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 18 years. It helps to improve concentration, focus, and reduce impulsive behavior.
Dosage form: tablets
Active substance Dosage methylphenidate hydrochloride 10 mg ATC: N06BA04
-
The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 18 years. It helps to improve concentration, extend attention span, and reduce impulsive behavior.
Dosage form: tablets
Active substance Dosage methylphenidate hydrochloride 20 mg ATC: N06BA04
-
The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 18 years. It helps to improve concentration, extend attention span, and reduce impulsive behavior.
Dosage form: tablets
Active substance Dosage methylphenidate hydrochloride 5 mg ATC: N06BA04
-
The medicinal product is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It may help to extend attention span, improve concentration, and reduce impulsive behavior.
Dosage form: capsules, hard modified release
Active substance Dosage methylphenidate hydrochloride 10 mg ATC: N06BA04
-
The medicine is intended for the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It is used when previous methods, such as behavioral therapy or psychological counseling, have proven insufficient.
Dosage form: capsules, hard modified release
Active substance Dosage methylphenidate hydrochloride 20 mg ATC: N06BA04
-
The medicinal product is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It may help to extend attention span, improve concentration, and reduce impulsive behavior.
Dosage form: capsules, hard modified release
Active substance Dosage methylphenidate hydrochloride 30 mg ATC: N06BA04
-
The medicine is intended for the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It is used when previous methods, such as behavioral therapy or psychological counseling, have proven insufficient.
Dosage form: capsules, hard modified release
Active substance Dosage methylphenidate hydrochloride 40 mg ATC: N06BA04
-
The medicine is intended for the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It helps to improve concentration, extend attention span, and reduce impulsive behavior.
Dosage form: capsules, hard modified release
Active substance Dosage methylphenidate hydrochloride 5 mg ATC: N06BA04
-
The medicinal product is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It may help to extend attention span, improve concentration, and reduce impulsive behavior.
Dosage form: capsules, hard modified release
Active substance Dosage methylphenidate hydrochloride 50 mg ATC: N06BA04
-
The medicinal product is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age and in adults. It may help to extend attention span, improve concentration, and reduce impulsive behavior.
Dosage form: capsules, hard modified release
Active substance Dosage methylphenidate hydrochloride 60 mg ATC: N06BA04
-
The medicine is used in children (from 6 years of age) and adults for the treatment of an overactive bladder caused by neurological diseases, such as spinal cord injury or congenital spinal defects (spina bifida). It is used when symptoms are not controlled orally and when the patient empties the bladder using a catheter.
Dosage form: solution for bladder instillation
Active substance Dosage oxybutynin hydrochloride 1 mg/ml ATC: G04BD04
-
It is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years. It may help to extend attention span, improve concentration, and reduce impulsive behavior.
Dosage form: tablets
Active substance Dosage dextroamphetamine sulfate 5 mg ATC: N06BA02
-
It is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years. It may help to extend attention span, improve concentration, and reduce impulsive behavior.
Dosage form: tablets
Active substance Dosage dextroamphetamine sulfate 10 mg ATC: N06BA02
-
It is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years. It may help to extend attention span, improve concentration, and reduce impulsive behavior.
Dosage form: tablets
Active substance Dosage dextroamphetamine sulfate 20 mg ATC: N06BA02